COMMUNIQUÉS West-GlobeNewswire

-
Basilea reports launch of antibiotic Zevtera (ceftobiprole) in Argentina by Grupo Biotoscana
06/03/2018 -
Novartis' Xolair® recommended in new global chronic urticaria guideline
06/03/2018 -
argenx to Present at Cowen & Company 38th Annual Health Care Conference
06/03/2018 -
Arcturus Therapeutics Calls on Proposed Director Nominees to Respond to Constructive Board Outreach
06/03/2018 -
Immutep Announces United States Patent Grant for IMP701 Antibody
06/03/2018 -
HealthEquity Sets Date to Announce Year-end Results
05/03/2018 -
Proteon Therapeutics Completes Enrollment in PATENCY-2, Phase 3 Clinical Trial of Investigational Vonapanitase
05/03/2018 -
MPX Bioceutical Corporation to Host Investor Conference Call on March 8, 2018
05/03/2018 -
Amarin Announces Closing of Underwriter’s Purchase of Additional Shares
05/03/2018 -
Teligent, Inc. to Present at the Raymond James 39th Annual Institutional Investors Conference on Wednesday March 7, 2018
05/03/2018 -
Cerner Announces New Collaboration with Salesforce to Extend Care Beyond the Exam Room
05/03/2018 -
Retrophin Announces Appointment of Casey Logan as Vice President of Corporate Development
05/03/2018 -
Dynavax to Present at the Cowen & Co. Annual Health Care Conference
05/03/2018 -
G1 Therapeutics Announces Proposed Offering of Common Stock
05/03/2018 -
AnaptysBio Announces Fourth Quarter and Full Year 2017 Financial Results and 2018 Pipeline Milestones
05/03/2018 -
SELLAS Life Sciences to Present at the 30th Annual ROTH Conference
05/03/2018 -
Analogic Announces Results for the Second Quarter ended January 31, 2018 and Declares Quarterly Cash Dividend
05/03/2018 -
Portola Pharmaceuticals to Host Webcast Event and Conference Call at ACC.18 to Discuss Late-Breaking Oral Presentation Highlighting New Interim Data for Andexanet Alfa
05/03/2018 -
GBT Announces Participation at Upcoming Investor Conferences in March
05/03/2018
Pages